Amphastar Taps Private Financing After Major Eli Lilly Acquisition

US-Based Firm Looks To Raise Hundreds Of Millions After Splashing Out On Brand

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.